Latest Advanced Prostate Cancer News2025-03-09T11:34:54-04:00

On The Horizon- FDA Grants Fast Track Designation for OGX-011 in The Treatment of Prostate Cancer

OncoGenex Pharmaceuticals, Inc. (OGXI) announced that it's experimental product, OGX-011, also known as custirsen sodium, received fast track designation from the U.S. Food & Drug Administration (FDA) for the treatment of progressive metastatic prostate cancer [...]

The Effect of Diabetes on Prostate Cancer Mortality

Concerned that your diabetes could making you more vulnerable to dying from prostate cancer? Yes, diabetes sufferers should be concerned about a potential shorter life span, but not as of a result of prostate cancer [...]

Distress, Anxiety and Depression in Prostate Cancer Patients

There have been a number of articles that claim that older cancer patients report less distress than younger cancer patients report. However, this research has generally not sorted the differences among general distress, anxiety, and [...]

On The Horizon – Sunitinib Malate for Metastatic Castration-Resistant Prostate Cancer Following Docetaxel Chemotherapy

Dr. Guru Sonpavde, MD (Clinical Assistant Professor, Baylor College of Medicine) reported about an open label, phase II trial of sunitinib (Sunitinib, marketed as Sutent, and previously known as SU11248 is an oral, small-molecule, multi-targeted [...]

Go to Top